Cargando…
The efficacy of direct oral anticoagulants in patients on concomitant treatment with levetiracetam
Guidelines do not support the combination of direct oral anticoagulants (DOACs) and the antiepileptic drug levetiracetam, due to potential relevant P-glycoprotein (P-gp) mediated interaction that might result in decreased DOACs concentrations and increased thromboembolic risk. However, there is no s...
Autores principales: | Mavri, Alenka, Ilc, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247761/ https://www.ncbi.nlm.nih.gov/pubmed/37286616 http://dx.doi.org/10.1038/s41598-023-33876-8 |
Ejemplares similares
-
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk
por: Cid, Allison, et al.
Publicado: (2022) -
Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient
por: Nwaedozie, Somto T, et al.
Publicado: (2021) -
Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort
por: Said, Ahmad, et al.
Publicado: (2020) -
Prescription patterns of direct oral anticoagulants and concomitant use of interacting medications in the Netherlands
por: Harskamp, R. E., et al.
Publicado: (2021) -
Efficacy of Levetiracetam in Treatment of Childhood Stuttering
por: Ghazavi, Mohammadreza, et al.
Publicado: (2020)